Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INEOS Oxide is a leading global producer of ethylene oxide, propylene oxide, and their diverse range of derivatives, serving as a foundational supplier to the healthcare and pharmaceutical sectors. The company is a critical provider of high-purity ethylene oxide, which is used to sterilize approximately 50% of all medical devices globally, including surgical instruments and implantable devices. Additionally, INEOS Oxide manufactures essential chemical intermediates such as ethanolamines and alkoxylates, which are utilized in the production of pharmaceuticals, agrochemicals, and personal care products. With major manufacturing hubs in Europe and the United States, the company provides large-scale industrial capacity and technical expertise in complex chemical synthesis. Its products are indispensable for maintaining global medical hygiene standards and supporting the synthesis of various therapeutic agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ineos Oxide.